CAR-T for r/r Malignant Tumors in Children

NCT04691349 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

CAR-T
Child, Only
Malignant Tumor

Interventions

DRUG: CAR-T

Sponsor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.